Capelieva 500mg Tablet: Advanced Oral Chemotherapy for Targeted Oncology CareAre you searching for a reliable Capelieva 500mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of oral chemotherapeutic agents. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Capelieva 500mg? Capelieva 500mg is an oral targeted chemotherapy containing the active pharmaceutical ingredient Capecitabine. Manufactured by Allieva Pharma Pvt Ltd, this 500mg tablet belongs to the category of antimetabolites. It is specifically designed to interfere with the growth and reproduction of cancer cells, serving as a cornerstone in modern oncology protocols. 1. Therapeutic Indications Colorectal Cancer: Used as a primary treatment for colon and rectal cancers, both as monotherapy and in combination regimens. Breast Cancer: Indicated for metastatic breast cancer, particularly in patients who have not responded to other chemotherapy treatments like taxanes or anthracyclines. Gastric (Stomach) Cancer: Effectively used in the treatment of advanced gastric and esophageal junction cancers. Adjuvant Therapy: Used post-surgery to prevent the recurrence of cancer in the colon after complete tumor removal. 2. Mechanism of Action: Targeted Cytotoxic Effect Prodrug Activation: Once ingested, Capecitabine is converted by enzymes into 5-fluorouracil (5-FU). Targeted Cell Death: This conversion primarily occurs within tumor tissues, where 5-FU hampers the synthesis of genetic materials (DNA), directly interfering with the growth of cancer cells. Selective Action: By targeting rapidly dividing cells, it slows down and eventually kills the malignant cells while attempting to minimize impact on healthy tissue. 3. Administration and Cycle Management Standard Dosing: Typically taken twice daily, Capelieva follows a specific cycle (often 14 days of treatment followed by a 7-day rest period). Timing: Must be taken within 30 minutes after a meal with a full glass of water. Form: Capsules must be swallowed whole; do not crush, chew, or break them Clinical Side Effects & Safety Monitoring Hand-Foot Syndrome: Redness, pain, or blisters on the palms and soles (Palmar-plantar erythrodysaesthesia). Gastrointestinal Health: Potential for diarrhea, nausea, vomiting, and mouth ulcers. Hematological Safety: Risk of increased infection due to changes in white blood cell counts. General Vitality: Loss of appetite, fatigue, and hair loss are common but manageable side effects. Why Source Capelieva 500mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Capelieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us
